Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

British drugmaker AstraZeneca Plc (NYSE: AZN) has emerged as the leading contender to acquire French biotech Abivax SA (NASDAQ: ABVX), following the company's dramatic valuation surge after strong clinical progress tied to its lead drug candidate.